Gilead Sciences to Present at Two Upcoming Investor Conferences

  Gilead Sciences to Present at Two Upcoming Investor Conferences

         - 2013 Citi Global Healthcare Conference on February 26^th -
    - 2013 RBC Capital Markets’ Healthcare Conference on February 27^th -
           - Webcasts Available Through Gilead Corporate Website -

Business Wire

FOSTER CITY, Calif. -- February 25, 2013

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the company will be
webcasting its corporate presentation at two upcoming investor conferences:
the Citi Global Healthcare Conference and the RBC Capital Markets’ Healthcare
Conference, both taking place in New York.

Robin Washington, Gilead’s Senior Vice President and Chief Financial Officer,
will provide an overview of the company at the Citi conference on Tuesday,
February 26 at 11:05 a.m. Eastern Time (ET) and the RBC conference on
Wednesday, February 27 at 10:30 a.m. ET.

To access the live webcasts or replays via the Internet log on to
www.gilead.com. Please connect to the company’s website at least 15 minutes
prior to the start of the presentation to ensure adequate time for any
software download that may be necessary to listen to the webcast. The replay
will be available for 14 days following the presentation.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and
commercializes innovative therapeutics in areas of unmet medical need. The
company’s mission is to advance the care of patients suffering from
life-threatening diseases worldwide. Headquartered in Foster City, California,
Gilead has operations in North America, Europe and Asia Pacific.

 For more information on Gilead Sciences, please visit www.gilead.com or call
   the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

Contact:

Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936 (Investor Relations)